Menstrual Cycle clinical trials

Explore recruiting menstrual cycle clinical trials.

Recruiting menstrual cycle studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Menstrual Cycle trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

C4951063: An interventional efficacy and safety, Phase 3, double-blind, parallel group study to investigate intermittent prevention of Menstrual Migraine with Rimegepant compared with placebo in women participants 18 to 45 years of age

Netherlands, Italy, Poland, Denmark, Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 years of age) with Schizophrenia

Romania, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Live birth after additional tubal flushing with oil-based contrast versus no additional flushing: a randomised, multicentre, parallel group pragmatic trial in infertile women with at least one patent tube at Hysterosalpingo-foam sonography

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

2-year, Multicentre, Open-label, Flexible-dose Study to Evaluate the Safety and Tolerability of Cariprazine in the Treatment of Adolescent Patients with Schizophrenia

Romania, Bulgaria, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Atogepant in Pediatric Subjects 6 to 17 years of age with Migraine

Belgium, Denmark, Italy, Netherlands, Poland, Spain +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Clinical Trial of Tirzepatide (LY3298176) in Subjects With Overweight or Obesity and PCOS-related Ovarian Dysfunction (PERIODS)

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Menstrual Cycle trials by city

Menstrual Cycle in Toronto Menstrual Cycle in Vancouver Menstrual Cycle in Montreal Menstrual Cycle in Calgary Menstrual Cycle in Edmonton Menstrual Cycle in Ottawa Menstrual Cycle in Winnipeg Menstrual Cycle in Quebec City Menstrual Cycle in Hamilton Menstrual Cycle in Kitchener Menstrual Cycle in London Menstrual Cycle in Halifax Menstrual Cycle in New York Menstrual Cycle in Los Angeles Menstrual Cycle in Chicago Menstrual Cycle in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease